Table 2.
Index | group | First Period | Second Period | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Before intervention | After intervention | Before intervention | After intervention | ||||||||||||
N | Mean | SD | N | Mean | SD | P-value | N | Mean | SD | N | Mean | SD | P-value | ||
Orientation | Aa | 19 | 9.68 | 0.58 | 19 | 9.95 | 0.23 | 0.059 | 17 | 9.94 | 0.24 | 17 | 9.94 | 0.24 | 1.00 |
B | 20 | 9.50 | 1.10 | 20 | 9.60 | 1.00 | 0.157 | 20 | 9.60 | 1.05 | 20 | 9.85 | 0.27 | 0.101 | |
P-value | – | 0.923 | – | 0.428 | – | 0.619 | – | 0.641 | |||||||
Immediate memory | Aa | 19 | 2.95 | 0.23 | 19 | 3.00 | 0.00 | 0.317 | 17 | 3.00 | – | 17 | 3.00 | 0.00 | 1.00 |
B | 20 | 2.75 | 0.44 | 20 | 2.85 | 0.37 | 0.157 | 20 | 2.75 | 0.64 | 20 | 2.80 | 0.62 | 0.317 | |
P-value | – | 0.296 | – | 0.428 | – | – | 0.442 | – | 0.619 | ||||||
Concentration and calculation | Aa | 19 | 3.58 | 1.22 | 19 | 4.05 | 1.08 | 0.014 | 17 | 3.71 | 1.10 | 17 | 3.71 | 1.26 | 1.00 |
B | 20 | 3.75 | 1.25 | 20 | 3.75 | 1.19 | 1.00 | 20 | 3.75 | 1.37 | 20 | 4.05 | 1.19 | 0.014 | |
P-value | – | 0.708 | – | 0.531 | – | – | 0.940 | – | 0.424 | – | |||||
Remembrance | Aa | 19 | 2.53 | 0.61 | 19 | 2.84 | 0.37 | 0.014 | 17 | 2.59 | 0.51 | 17 | 2.65 | 0.49 | 0.317 |
B | 20 | 2.40 | 0.68 | 20 | 2.40 | 0.75 | 1.00 | 20 | 2.35 | 0.74 | 20 | 2.55 | 0.69 | 0.046 | |
P-value | – | 0.627 | – | 0.095 | – | – | 0.442 | – | 0.869 | – | |||||
Language and understanding | Aa | 19 | 7.53 | 0.61 | 19 | 7.74 | 0.56 | 0.102 | 17 | 7.65 | 0.70 | 17 | 7.71 | 0.69 | 0.564 |
B | 20 | 7.40 | 1.00 | 20 | 7.55 | 0.83 | 0.083 | 20 | 7.50 | 0.89 | 20 | 7.65 | 0.67 | 0.083 | |
P-value | – | 0.923 | – | 0.607 | – | – | 0.729 | – | 0.752 | – | |||||
Space situation | Aa | 19 | 0.47 | 0.51 | 19 | 0.47 | 0.51 | 1.00 | 17 | 0.41 | 0.51 | 17 | 0.41 | 0.51 | 1.00 |
B | 20 | 0.40 | 0.50 | 20 | 0.40 | 0.50 | 1.00 | 20 | 0.40 | 0.50 | 20 | 0.45 | 0.51 | 0.317 | |
P-value | – | 0.708 | – | 0.708 | – | – | 0.964 | – | 0.845 | – | |||||
Cognitive impairment (general) | Aa | 19 | 26.74 | 2.92 | 19 | 28.05 | 2.01 | 0.003 | 17 | 27.29 | 2.44 | 17 | 27.41 | 2.57 | 0.527 |
B | 20 | 26.20 | 4.21 | 20 | 26.55 | 4.10 | 0.068 | 20 | 26.35 | 4.44 | 20 | 27.35 | 3.53 | 0.005 | |
P-value | – | 0.901 | – | 0.461 | – | – | 0.821 | – | 0.707 | – |
aThe group A took valerian capsules in the first therapeutic period of one month and placebo in the second therapeutic period of one month, and vice versa in group B